Source: StreetInsider

Press Release: Biocartis : Press Release Biocartis NV: Biocartis Announces Launch of the Brand-New Idylla POLE-POLD1 Mutation Assay

PRESS RELEASE 02/04/2025, 07:00 CEST Biocartis Announces Launch of the Brand-New Idylla POLE-POLD1 Mutation Assay Mechelen, Belgium, 02 April 2025 Biocartis NV (Biocartis), an innovative...

Read full article »

Biocartis's Competitors | Biocartis's News | Biocartis's Financials

Followers on Owler

Est. Annual Revenue

$25-100M

Est. Employees

250-500

CEO

Roger Moody

CEO Approval Rating

85/100

Biocartis is a Belgium-based diagnostics company that provides testing solutions for the treatment of cancer and infectious diseases with a focus on oncology.